Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Randomisation and Study Treatment Participants were randomised in a 1:1 ratio to either active treatment with exenatide (Byetta) or placebo using a computer-generated randomisation list compiled by the Birmingham Clinical Trials Unit
Still, 9 years later and we don't have a final ruling
Similar content being viewed by others Introduction Type 2 diabetes (T2D) is the leading cause of end-stage kidney disease (ESKD) globally [1]
PAUSE AND PONDER: Which of Evas symptoms are red flags
US$ 27.61
US$ 25.46
US$ 21.99
&srotate=0)
US$ 24.73
US$ 27.73
